Similar articles

• Early post-procedural migraine attack predicts migraine resolution after patent foramen ovale transcatheter closure.

  Rigatelli G, Cardaioli P, Dell'Avvocata F, Braggion G, Giordan M, Chinaglia M. Rigatelli G, et al. Minerva Cardioangiol. 2008 Oct;56(5):461-5. Minerva Cardioangiol. 2008. PMID: 18813181
• Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.

  O'Gara PT, Messe SR, Tuzcu EM, Catha G, Ring JC; American Heart Association; American Stroke Association; American College of Cardiology Foundation. O'Gara PT, et al. J Am Coll Cardiol. 2009 May 26;53(21):2014-8. doi: 10.1016/j.jacc.2009.04.001. J Am Coll Cardiol. 2009. PMID: 19460622
• Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.

  O'Gara PT, Messe SR, Tuzcu EM, Catha G, Ring JC; American Heart Association; American Stroke Association; American College of Cardiology Foundation. O'Gara PT, et al. Circulation. 2009 May 26;119(20):2743-7. doi: 10.1161/CIRCULATIONAHA.109.192272. Epub 2009 May 11. Circulation. 2009. PMID: 19433754
• When to close a patent foramen ovale.

  Kenny D, Turner M, Martin R. Kenny D, et al. Arch Dis Child. 2008 Mar;93(3):255-9. doi: 10.1136/adc.2006.110098. Epub 2007 Sep 7. Arch Dis Child. 2008. PMID: 17827196 Review.
• Patent foramen ovale: clinical manifestations and treatment.

  Kedia G, Tobis J, Lee MS. Kedia G, et al. Rev Cardiovasc Med. 2008 Summer;9(3):168-73. Rev Cardiovasc Med. 2008. PMID: 18953276 Review.